Stock ALCLS CELLECTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Cellectis S.A.

Equities

ALCLS

FR0010425595

Market Closed - Euronext Paris
Other stock markets
 11:35:19 2024-05-02 EDT 		5-day change 1st Jan Change
2.6 EUR +6.78% Intraday chart for Cellectis S.A. +7.44% -5.93%
05-02 European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT
04-29 Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
GL
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GL
Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
AQ
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
GL
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
GL
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
GL
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
PU
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
PU
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024
AQ
Cellectis announces the drawdown of the second tranche of EUR15 million under the credit facility agreement entered with the European Investment Bank
AQ
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
GL
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
AQ
Cellectis S A : Vote Results General Shareholders’ Meeting December 22, 2023
PU
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
GL
Cellectis S A : Extraordinary Resolutions - Form 6-K
PU
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)
AQ
Cellectis S A : Depositary's Notice of Combined Ordinary and Extraordinary General Meeting of Cellectis S.A - Form 6-K
PU
Cellectis Shareholders Meeting to be Held on December 22, 2023
AQ
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
GL
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALCLS Stock
  4. News Cellectis S.A.
  5. Press Releases